BISON, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.651
EU - Europa 170
AS - Asia 143
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.966
Nazione #
US - Stati Uniti d'America 1.649
CN - Cina 129
IT - Italia 61
FI - Finlandia 34
SE - Svezia 30
DE - Germania 13
GB - Regno Unito 13
NL - Olanda 6
IN - India 5
UA - Ucraina 4
VN - Vietnam 4
BE - Belgio 3
IE - Irlanda 3
CA - Canada 2
EU - Europa 2
JP - Giappone 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IQ - Iraq 1
PK - Pakistan 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 1.966
Città #
Fairfield 299
Chandler 192
Woodbridge 182
Ashburn 155
Houston 132
Cambridge 119
Ann Arbor 95
Seattle 94
Wilmington 84
Beijing 48
Princeton 27
San Diego 27
Medford 22
Des Moines 20
Helsinki 19
Padova 17
Jacksonville 13
Nanjing 13
Roxbury 12
New York 11
Boardman 10
Hebei 8
Nanchang 7
Dearborn 6
Hefei 6
Shenyang 6
Milan 5
Ho Chi Minh City 4
Jiaxing 4
Jinan 4
Brussels 3
Dublin 3
Genoa 3
Ogden 3
Pune 3
Redwood City 3
Vicenza 3
Zhengzhou 3
Agrigento 2
Bertinoro 2
Bethel Park 2
Bussero 2
Changsha 2
Florence 2
London 2
Ningbo 2
Norwalk 2
Ospedaletto Euganeo 2
Ponte di Piave 2
Savona 2
Tappahannock 2
Tianjin 2
Tokyo 2
Agordo 1
Borås 1
Buffalo 1
Carol Stream 1
Columbus 1
Edinburgh 1
Falkenstein 1
Fragneto Monforte 1
Geislingen an der Steige 1
Guangzhou 1
Haikou 1
Kilburn 1
Kunming 1
Lisbon 1
Orange 1
Pearland 1
Prescot 1
Saint Louis 1
Stockholm 1
Taiyuan 1
Taizhou 1
Treviso 1
Washington 1
Yuncheng 1
Totale 1.719
Nome #
Diagnosis and therapy of antiphospholipid syndrome 121
Laboratory testing for antiphospholipid syndrome 117
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 112
Interpretation of laboratory data and need for reference laboratories. 106
The Paradox of the Lupus Anticoagulant: History and Perspectives 106
APS - Diagnostics and challenges for the future 104
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 100
Antiphospholipid syndrome: critical analysis of the diagnostic path 99
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 97
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 95
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 94
Correct laboratory approach to APS diagnosis and monitoring 92
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 83
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 82
Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability 79
Confirmation of the initial antiphospholipid antibody positivity depends on antiphospholipid antibody profile 79
Secondary prevention in thrombotic antiphospholipid syndrome. 76
Laboratory Diagnostics of Antiphospholipid Syndrome 72
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study 60
The role of platelets in antiphospholipid syndrome 57
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 48
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 44
Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis 38
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 31
Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature 9
Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? 3
Totale 2.004
Categoria #
all - tutte 6.974
article - articoli 6.974
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019205 0 0 0 0 0 0 0 0 0 42 88 75
2019/2020444 58 17 5 29 44 33 58 53 48 54 28 17
2020/2021244 19 24 7 21 6 35 16 26 35 15 24 16
2021/2022369 10 40 51 25 8 22 19 50 11 13 32 88
2022/2023354 61 40 7 50 43 48 4 27 35 8 25 6
2023/2024163 4 18 18 27 12 30 19 20 6 9 0 0
Totale 2.004